Cited by 557Multiple Sclerosis Research StudiesPsoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis

Kebir, Hania, Ifergan, Igal, Alvarez, Jorge Ivan, Bernard, Monique, Poirier, Josée, Arbour, Nathalie, Duquette, Pierre, Prat, Alexandre·2009·Annals of Neurology

DOI 10.1002/ana.21748

Open this paper in CoChat — free account

Abstract

Objective: There is substantial evidence supporting the role of interferon (IFN)‐γ–producing T helper (T H ) 1 and interleukin (IL)‐17–expressing T H 17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN‐γ–expressing T H 17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). Methods: Human T H 17 lymphocytes were expanded in vitro from the blood of healthy controls and relapsing MS patients using IL‐23. Immune cell migration to the CNS was assessed in vitro with primary cultures of human blood–brain barrier (BBB)‐derived endothelial cells, and in vivo in EAE mice. Results: We demonstrate that in response to IL‐23, human memory lymphocytes expand into a T H 17 phenotype, with a subpopulation of cells simultaneously expressing IFN‐γ and IL‐17. We note that lymphocytes obtained from the blood of relapsing MS patients have an increased propensity to expand into IFN‐γ–producing T H 17 cells and identify numerous T lymphocytes coexpressing IL‐17 and IFN‐γ in brain tissue of MS patients. We also find lymphocytes expressing both the T H 1‐ and the T H 17‐associated transcription factors RORγt and T‐bet, in situ and in vitro. We further provide in vitro and in vivo evidence that IFN‐γ + T H 17 lymphocytes preferentially cross the human BBB and accumulate in the CNS of mice during the effector phase of EAE. Interpretation: Our data underscore the involvement of IFN‐γ + T H 17 lymphocytes in the pathology of MS and EAE and their preferential recruitment into the CNS during inflammatory events. Ann Neurol 2009;66:390–402

Integrity signals

Registry

Crossref · 10.1002/ana.21748

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Self-citation

Flagged first, then by citations

Show all 39 references

Sorted by citations

Items 401–500 of 557

The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study
Larsen, J. B., Reitan, S. K., Løberg, E., Rettenbacher, M. A., Bruserud, Ø., Larsen, T. K., Anda, L. G., Bartz-Johannessen, C. A., Johnsen, E., & Kroken, R. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100392 · Cited by 9
Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease
Dhaeze, T., Lachance, C., Tremblay, L., Grasmuck, C., Bourbonnière, L., Larouche, S., Saint‐Laurent, O., Lécuyer, M., Rébillard, R., Zandee, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124885 · Cited by 9
Self-citation
Multiple Sclerosis
Segal, B. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00066-1 · Cited by 9
The interplay between Epstein-Barr virus DNA and gut microbiota in the development of arthritis in a mouse model
Fadlallah, S. M., Bitar, E. R., Hussein, H. M., Jallad, M.-A., Matar, G. M., & Rahal, E. A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02042-23 · Cited by 8
Migration arrest and transendothelial trafficking of human pathogenic-like Th17 cells are mediated by differentially positioned chemokines
Parween, F., Singh, S. P., Kathuria, N., Zhang, H. H., Ashida, S., Otaizo-Carrasquero, F. A., Shamsaddini, A., Gardina, P. J., Ganesan, S., Kabát, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57002-6 · Cited by 13
The role of interleukin-23 in stability of in vitro T helper-17 cells.
Taherian, M., Razavi, A. R., Izad, M. H., Boghozian, R., Namdari, H., Ghaedi, M., Rahimzadeh, P., Bidad, K., & Salehi, E. (2014) · PubMed · Cited by 8
The role of vitamin D and P2X7R in multiple sclerosis
Voo, V. T. F., O'Brien, T. J., Butzkueven, H., & Monif, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.004 · Cited by 9
Inhibition of G-Protein βγ Signaling Decreases Levels of Messenger RNAs Encoding Proinflammatory Cytokines in T Cell Receptor-Stimulated CD4+ T Helper Cells
Hynes, T. R., Yost, E. A., Hartle, C. M., Ott, B. J., & Berlot, C. H. (2015) · Journal of Molecular Signaling · doi:10.5334/1750-2187-10-1 · Cited by 8
The Role of Th17 Cells in Immunopathogenesis of Neuroinflammatory Disorders
Pourgholaminejad, A., & Tahmasebinia, F. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_3 · Cited by 8
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
Cummings, M., Arumanayagam, A., Zhao, P., Kannanganat, S., Stüve, O., Karandikar, N., & Eagar, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200752 · Cited by 7
Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model
Nakamura, Y., Igaki, K., Uga, K., Shibata, A., Yamauchi, H., Yamasaki, M., & Tsuchimori, N. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577016 · Cited by 7
Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
Biernacki, T., Sandi, D., Bencsik, K., & Vécsei, L. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191015201755 · Cited by 8
Sportizumab – Multimodal progressive exercise over 10 weeks decreases Th17 frequency and CD49d expression on CD8+ T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial
Proschinger, S., Belen, S., Adammek, F., Schlagheck, M. L., Rademacher, A., Schenk, A., Warnke, C., Bloch, W., & Zimmer, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.017 · Cited by 6
Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis
Pape, K., Hanuscheck, N., Schmaul, S., Kneilmann, F., Bündgen, G., Wasser, B., Steffen, F., Engel, S., Luessi, F., Klein, M., et al. (2025) · Brain · doi:10.1093/brain/awaf268 · Cited by 5
Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
Arimitsu, N. N., Witkowska, A., Ohashi, A., Miyabe, C., & Miyabe, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547256 · Cited by 6
MOG-Specific T Cells Lead to Spontaneous EAE with Multilocular B Cell Infiltration in the GF-IL23 Model
Nitsch, L., Petzinna, S. M., Zimmermann, J., Getts, D. R., Becker, A. J., & Müller, M. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08705-2 · Cited by 7
Proximal and Distal Regions of Pathogenic Th17 Related Chromatin Loci Are Sequentially Accessible During Pathogenicity of Th17
Hu, L., Zhao, X., Li, P., Zeng, Y., Zhang, Y., Shen, Y., Wang, Y., Sun, X., Lai, B., & Zhong, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864314 · Cited by 6
Ingested (oral) anti-IL-12/23 inhibits EAE
Brod, S. A. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.011 · Cited by 6
MS AHI1 genetic risk promotes IFNγ + CD4 + T cells
Kaskow, B. J., Buttrick, T., Klein, H., White, C. C., Bourgeois, J. R., Ferland, R. J., Patsopoulos, N. A., Bradshaw, E. M., Jager, P. L. D., & Elyaman, W. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000414 · Cited by 6
Immune Tolerance in Autoimmune Central Nervous System Disorders
Jayaraman, S., & Prabhakar, B. S. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_5 · Cited by 6
Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis
Bréville, G., Benkhoucha, M., Rezk, A., Tran, N. L., Senoner, I., Bar‐Or, A., & Lalive, P. H. (2025) · Annals of Neurology · doi:10.1002/ana.78035 · Cited by 5
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_1 · Cited by 6
Respiratory tract Moraxella catarrhalis and Klebsiella pneumoniae can promote pathogenicity of myelin-reactive Th17 cells
Mannion, J. M., Segal, B. M., McLoughlin, R. M., & Lalor, S. J. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.04.003 · Cited by 7
Immunology of Multiple Sclerosis
Wu, G. F., & Cross, A. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_9 · Cited by 5
Melanoma Cell Adhesion Molecule Expressing Helper T Cells in CNS Inflammatory Demyelinating Diseases
Ikeguchi, R., Shimizu, Y., Kondo, A., Kanda, N., So, H., Kojima, H., & Kitagawa, K. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001069 · Cited by 5
Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis
Lovett‐Racke, A. E., & Racke, M. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811709-5.00005-3 · Cited by 5
Chemokine receptors on T cells in multiple sclerosis
Sato, W. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12130 · Cited by 5
The complex immunology of multiple sclerosis
Owens, T. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514521312 · Cited by 5
Human IL-17A protein production is controlled through a PIP5K1α-dependent translational checkpoint
Revu, S. K., Yang, W., Rajasundaram, D., Brady, A., Majumder, S., Gaffen, S. L., Hawse, W. F., Xia, Z., & McGeachy, M. J. (2023) · Science Signaling · doi:10.1126/scisignal.abo6555 · Cited by 4
Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyelitis
Pedersen, D. S., Tran, T. P., Smidt, K., Bibby, B. M., Rungby, J., & Larsen, A. (2013) · BioMetals · doi:10.1007/s10534-013-9616-4 · Cited by 4
CD20+ T cells in multiple sclerosis
Schneider, R. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.09.213 · Cited by 4
Calpain inhibition as a possible new therapeutic target in multiple sclerosis
Smith, A. W., Ray, S. K., Das, A., Nozaki, K., Rohrer, B., & Banik, N. L. (2017) · AIMS molecular science · doi:10.3934/molsci.2017.4.446 · Cited by 4
Cytokine Secretion Dynamics of Isolated PBMC after Cladribine Exposure in RRMS Patients
Bălașa, R., Maier, S., Huţanu, A., Voidăzan, S. T., Andone, S. R., Oiaga, M. C., & Manu, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810262 · Cited by 4
Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis
Brune, S., Høgestøl, E. A., de Rosbo, N. K., Berg‐Hansen, P., Brunborg, C., Blennow, K., Zetterberg, H., Paul, F., Uccelli, A., Villoslada, P., et al. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578175 · Cited by 4
Th17 Cells in Autoimmune Inflammation and Demyelination in the Central Nervous System
Kuchroo, V. K., & Korn, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7953-6_1 · Cited by 4
Fingolimod: Una novedosa terapia, modulador de los receptores de esfingosina para las formas recurrentes de esclerosis múltiple
Flores-Rivera, J. D. J. (2011) · Cited by 4
Th17 cell-Mediated Responses in Type 1 Diabetes Pathogenesis
Yaochite, J. N. U. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s10-006 · Cited by 4
Immunomonitoring Lymphocyte Subpopulations in Multiple Sclerosis Patients
Teniente‐Serra, A., Ramo-Tello, C. M., & Martínez-Cáceres, E. M. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch9 · Cited by 4
Alterations in circulating T cell functional subpopulations in interferon-beta treated multiple sclerosis patients: A pilot study
Monteiro, A., Rosado, P., Rosado, L. E. P., Fonseca, A. M., & Paiva, A. A. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577113 · Cited by 4
Ca2+ Signaling Augmented by ORAI1 Trafficking Regulates the Pathogenic State of Effector T Cells
Wu, B., Woo, J. S., Sun, Z., Srikanth, S., & Gwack, Y. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100871 · Cited by 4
Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential
Guo, W.-M., Meydani, S., & Wu, D.-Y. (2026) · Nutrients · doi:10.3390/nu18020278 · Cited by 4
Cellular Immunity and Multiple Sclerosis: Current Understanding
Sato, W., & Yamamura, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_1 · Cited by 2
Markers of Th1 polarized Th17 cells (literature review)
Куклина, Е. М., & Glebezdina, N. S. (2023) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2023-8.3.5 · Cited by 3
Epstein–Barr Virus DNA Exacerbates Arthritis in a Mouse Model via Toll-like Receptor 9
Sherri, N., Assaf, R., Bitar, E. R., Znait, S., Borghol, A. H., Kassem, A. H., & Rahal, E. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094661 · Cited by 3
Blood-Brain Barrier Disruption in Multiple Sclerosis
van Doorn, R. (2015) · CRC Press eBooks · doi:10.1201/b19299-4 · Cited by 3
Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
Boldrini, V. D. O., de Brito, M. R., Quintiliano, R. P. S., Silva, L. S., Yasuda, C. L., Cendes, F., Farias, A. S., & Damasceno, A. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1208977 · Cited by 3
Unraveling the Immunopathogenesis of Multiple Sclerosis: The Dynamic Dance of Plasmablasts and Pathogenic T Cells
Matsuzaka, Y., & Yashiro, R. (2023) · Biologics · doi:10.3390/biologics3030013 · Cited by 3
Hemp seed/evening primrose oil affects expression of STAT3, IL-17, and FOXP3 + in experimental autoimmune encephalomyelitis
Mohammadzadeh, A., Rezapour-Firouzi, S., Kheradmand, F., Shahabi, S., Tehrani, A., & Mazloomi, E. (2019) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.253362 · Cited by 3
Role of effector T cells in multiple sclerosis
Chihara, N. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12594 · Cited by 3
Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis
Yang, Y., Lovett‐Racke, A. E., & Racke, M. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00006-x · Cited by 3
Distinct cytokine and T helper cell profiles between patients with multiple sclerosis who had or had not received interferon‐beta
Doi, H., Song, Z., Yoshimura, S., Tateishi, T., Yonekawa, T., Yamasaki, R., Murai, H., Matsushita, T., & Kira, J. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12138 · Cited by 3
Th1-, Th17- und Th1+17-Zellen
Chang, H., Kamradt, T., & Schulze‐Koops, H. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0779-5 · Cited by 3
Multiple Sclerosis
Romeo, A. R., & Segal, B. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00066-6 · Cited by 5
Mood symptoms and chronic fatigue syndrome due to relapsing remitting multiple sclerosis are associated with immune activation and aberrations in the erythron.Preprint
Almulla, A. F., Jaleel, A.-K. K. A., Algon, A. A. A., Tunvirachaisakul, C., Hassoun, H. K., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Research Square · doi:10.21203/rs.3.rs-2569742/v1 · Cited by 3
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity
Ma, Y. N., Zhang, A., Lin, J. F., Ding, F., Wang, X., Wang, W., Jian, G., Zhang, J., Zhu, P., Ma, Y. N., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102700 · Cited by 2
Role of Th1 and Th2 in autoimmunity
Ramponi, G., Brunetta, E., & Folci, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822564-6.00020-3 · Cited by 2
Flow Cytometry Sorting of Memory CCR6+CD4+ T-Cells for HIV Reservoir Quantification
Cattin, A., Fert, A., Planas, D., & Ancuța, P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1871-4_7 · Cited by 2
Th17-Mediated Immune Responses in Pathogenesis of Neuroinflammatory Disorders
Pourgholaminejad, A., & Tahmasebinia, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_3 · Cited by 2
Treatment with a hybrid between the synapsin ABC domains and the B subunit of E. coli heat-labile toxin reduces frequency of proinflammatory cells and cytokines in the central nervous system of rats with EAE
Bibolini, M. J., Scerbo, M. J., Roth, G. A., & Monferrán, C. G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.070 · Cited by 2
The antimicrobial peptide cathelicidin is critical for the development of Th17 responses in severe inflammatory diseasePreprint
Smith, K. J., Minns, D., McHugh, B. J., Holloway, R. K., O’Connor, R. A., Williams, A., Melrose, L. A., McPherson, R. C., Miron, V. E., Davidson, D. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.27.477976 · Cited by 2
Identification of Th1-polarized Th17 cells: solving the problem
Куклина, Е. М., & Glebezdina, N. S. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-iot-2770 · Cited by 1
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?
Bianco, A. D., Sante, G. D., Colò, F., Arcangelis, V. D., Cicia, A., Giacomo, P. D., Bonis, M. D., Morganti, T., Carlomagno, V., Lucchini, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084556 · Cited by 1
Mechanisms of Glucocorticoid Resistance in Nonclassical T Helper Populations Th17.1/Ex-Th17
Куклина, Е. М. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604222 · Cited by 1
Overcoming Synthetic Challenges and Evaluating in Vivo Efficacy of the MOG-Fc-Bifunctional Peptide Inhibitor for EAE in Mice
Mahadik, R., Villela-Nava, A. L., Xin, L., Siahaan, T. J., & Tolbert, T. J. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00518 · Cited by 1
Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-β: is there a dichotomy into T-helper-1 and -17 driven disease?
Weissert, R. (2010) · Future Neurology · doi:10.2217/fnl.10.32 · Cited by 1
Generation and Expansion of T Helper 17 Lymphocytes Ex Vivo
Alizadeh, D., & Larmonier, N. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3139-2_7 · Cited by 1
Peripheral blood T cell subset characteristics of multiple sclerosis in remission phase correlate with annualized relapse rates
Song, Z., Nakamura, Y., Yamasaki, R., Kawano, Y., Shinoda, K., Maimaitijiang, G., Masaki, K., Yamaguchi, H., Matsushita, T., & Kira, J. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12321 · Cited by 1
Th17 Cells: Differentiation and Regulation
Chu, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28040-0_3 · Cited by 1
Cerebrospinal Fluid Markers in Neuroinflammation: The Paradigm of Optic Neuritis
Besinis, D., & Anagnostouli, M. C. (2017) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6843-5_14 · Cited by 1
Overview: The Paradox of Microbial Impact on the Immune System in Allergy Prevention and Exacerbation
Schmidt‐Weber, C. B. (2017) · Birkhäuser advances in infectious diseases · doi:10.1007/978-3-319-69968-4_1 · Cited by 1
Current advances in multiple sclerosis immunopathology
Cuevas-García, C., Segura-Méndez, N. H., & Herrera-Sánchez, D. A. (2018) · Gaceta Médica de México · doi:10.24875/gmm.m18000194 · Cited by 1
Blood-Brain Barrier Disruption in Multiple Sclerosis
Mizee, M. R., van Doorn, R., Prat, A., & de Vries, H. E. (2015) · CRC Press eBooks · doi:10.1201/b19299-2 · Cited by 1
Self-citation
Fc multimers effectively treat murine models of multiple sclerosis
Wang, J., Brown, K. N., Danehy, C., Mérigeon, E. Y., Goralski, S. M., Rice, S., Torgbe, K., Thomas, F., Block, D. S., Olsen, H. S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199747 · Cited by 1
Immune Tolerance in Autoimmune Central Nervous System Disorders
Jayaraman, S., & Prabhakar, B. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_5 · Cited by 1
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update
Raftopoulou, S., Kapsali, I., Evangelopoulos, M., & Mavragani, C. P. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2522270 · Cited by 2
Immune Dysregulation in Multiple Sclerosis
Regev, K., & Weiner, H. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00002-7 · Cited by 1
Roles of CD4 and CD8 T Lymphocytes in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Arbour, N., & Prat, A. (2015) · Wiley eBooks · doi:10.1002/9781118732748.ch3 · Cited by 1
Self-citation
Immunomodulation by adult stem cells
Davies, L. C., & Blanc, K. L. (2016) · doi:10.1002/9781119282181.ch2 · Cited by 1
Commensal-specific CD4 T cells promote inflammation in the central nervous system via molecular mimicryPreprint
White, Z., Cabrera, I., Ochoa-Raya, A., Kapustka, I., Koster, K. P., Matsuo, T., Jayawardena, D., Kageyama, T., Dudeja, P. K., Lutz, S. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.509786 · Cited by 1
Respiratory tract Moraxella catarrhalis and Klebsiella pneumoniae can promote pathogenicity of myelin-reactive Th17 cellsPreprint
Mannion, J. M., Segal, B., McLoughlin, R., & Lalor, S. (2023) · bioRxiv · doi:10.1101/2023.03.30.534905 · Cited by 5
The Role of Id Proteins in the Development and Function of T and B Lymphocytes
Lin, Y. (2014) · DukeSpace (Duke University)
Introduction
Cohen, J. A., & Rudick, R. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.004
Behandlung mit CDK5 Inhibitor bei der Myelin Oligodendrozyten Glykoprotein (MOG) induzierten experimentellen autoimmunen Encephalomyelitis (EAE)
Herlan, S. (2011)
T-cell-based therapies for multiple sclerosis
Chitnis, T., & Khoury, S. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.044
Development of Peptides to Target Antigen Presenting Cells for Controlling the Immune Response in Experimental Autoimmune Encephalomyelitis
Badawi, A. H. (2011) · KU ScholarWorks (The University of Kansas)
Review Article Role of toll-like receptors in multiple sclerosis
Miranda‐Hernandez, S., & Baxter, A. G. (2013)
The biology of CD4+ T cells in the blood and central nervous system
Voice, M. A. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Znaczenie wybranych populacji komórek immunologicznych w leczeniu zaostrzeń stwardnienia rozsianego z zastosowaniem plazmaferezy
Stasiołek, M. (2011)
The Role of NOTCH3 Signaling in T Helper Cell Differentiation and Induction of EAE
Ayaz, F. (2021) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/7602425.0
Clarifying the Critical Factors for Th1 and Th17 Pathogenicity in an Animal Model of CNS-Targeted Autoimmune Disease.
Grifka‐Walk, H. M. (2014) · Deep Blue (University of Michigan)
Pharmacological Inhibition of Cyclophilin Ameliorates Experimental Allergic Encephalomyelitis
Huang, Z. L. (2016) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/abe6-1h82
effect suppressor function increases up to 24 months
Mercanti, S. F. D., Rolla, S., Cucci, A., Bardina, V., Cocco, E. E., Vladić, A., Soldo-Butković, S., Habek, M., Adamec, I., Horáková, D., et al. (2016)
Immunologyof MS
Fletcher, J. M., & Mills, K. H. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979088.005
Leukocyte Entry into the Brain
Dorovini‐Zis, K., Wong, D. K., & Liu, K. (2015) · doi:10.1201/b18606-15
Generation of Tolerogenic Dendritic Cells for Cell Therapy in Multiple Sclerosis
Regué, D. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Expression et fonction des intégrines liant le collagène chez les lymphocytes Th1
Boisvert, M. (2013) · Corpus Université Laval (Université Laval)
The Role of Peroxisome Proliferator-activated Receptor Alpha in the Regulation of Sex Differences in T Helper 1 Immunity
Zhang, M. (2015) · TSpace (University of Toronto)
BACE1 is a novel regulator of Th17 function in EAE
Hernández-Mir, G. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
FUNCTIONAL REGULATION OF INTERLEUKIN-17 RECEPTOR SIGNALING
Cruz, J. A. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Characterization of the immunoregulatory roles of IFN-β in T cells and dendritic cells
Pennell, L. M. (2017) · TSpace (University of Toronto)

Authors: Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A.
Affiliations: Hôpital Notre-Dame (CA)
Corresponding author: Prat, Alexandre
ORCID: Ifergan, Igal
Alvarez, Jorge Ivan
Poirier, Josée
Arbour, Nathalie
Duquette, Pierre
Prat, Alexandre
Venue: Annals of Neurology
Publisher: Wiley
Published: 2009-09
Volume: 66
Issue: 3
Pages: 390-402
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.21748
OpenAlex: W2127568644
Cited by: 551
References: 39
Citations by year: 2026: 13 · 2025: 17 · 2024: 20 · 2023: 36 · 2022: 34 · 2021: 38 · 2020: 27 · 2019: 35 · 2018: 34 · 2017: 40 · 2016: 37 · 2015: 47 · 2014: 42 · 2013: 36 · 2012: 29
FWCI: 22.07
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 35 d)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: multiple sclerosis, experimental autoimmune encephalomyelitis, Th17 cells, interferon-gamma, IL-17, IL-23, blood-brain barrier, T-bet, memory T cells, relapsing multiple sclerosis
MeSH terms: Adult, Animals, Blood-Brain Barrier, Brain, Cell Migration Inhibition, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Interferon-gamma, Mice, Inbred C57BL, Middle Aged, Multiple Sclerosis, T-Lymphocytes, Th1 Cells, Th2 Cells, Interleukin-17, Multiple Sclerosis, Relapsing-Remitting, Mice, Interleukin-23, Cell Migration Assays, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks